Proteomics Market - Global Industry is Expecting Major Revenue Growth in Near Future

Overview of This Research:

This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies.

Secondary Research:

The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, companies house documents, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the proteomics market. It was also used to obtain important information about the key players and market classification & segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

Download PDF Brochure@ 

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=731

Primary Research:

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and related key executives from various key companies and organizations operating in the proteomics market. The primary sources from the demand side included industry experts, such as researchers and scientists, and industry experts from pharmaceutical & biotechnology companies. Primary research was conducted to validate the market segmentation, identify key players in the market, and gather insights on key industry trends & key market dynamics.

Expected Revenue Growth:

The proteomics market is projected to reach USD 38.7 billion by 2024 from USD 19.5 billion in 2019, at a CAGR of 14.7%. Growth in this market is driven by increasing research activity in the area of personalized medicine and drug discovery, increasing R&D expenditure by the pharmaceutical and biotechnology sector, and rising government funding for proteomics.

North America to dominate the proteomics market during the forecast period

In 2018, North America dominated the global proteomics market, followed by Europe. Increasing investments in the development of structure-based drug designs, growing academic and government investments in genomics and proteomics research, rising demand for high-quality research tools for data reproducibility, and rising focus of stakeholders on research projects involving proteins, associated biomolecules, and genes are the factors propelling the growth of the market in the region.

Request Sample Pages@ 

https://www.marketsandmarkets.com/requestsampleNew.asp?id=731

Global Leaders:

Prominent players in the proteomics market are Thermo Fisher Scientific, Inc. (US), Agilent Technologies, Inc.(US), GE Healthcare (US), Bio-Rad Laboratories, Inc. (US), Danaher Corporation (US), Luminex Corporation (US), Bruker Corporation (US), Merck KGaA,(Germany), Waters Corporation (US),  PerkinElmer, Inc. (US), Creative Proteomics (US), and Promega Corporation (US).

Proteomics Research Industry is Expecting Major Surge in Global Revenue in Near Future

This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies.

Objectives of the Study:

# To define, describe, segment, and forecast the global Proteomics Market by instrumentation technology, reagent, services and software, application, end user, and region

# To provide detailed information about the factors influencing market growth (such as drivers, restraints, opportunities, and industry-specific challenges).

# To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market.

# To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players.

# To forecast the size of the proteomics market in five main regions along with their respective key countries (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa).

# To profile key players in the global proteomics market and comprehensively analyze their core competencies and market shares.

# To track and analyze competitive developments such as acquisitions; product launches; expansions; collaborations, partnerships, & agreements; and R&D activities of the leading players in the proteomics market.

Download PDF Brochure@

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=731

The use of immunoassay reagents is increasing with the rising need for precise protein identification

Based on reagent, the proteomics market is segmented into protein microarray reagents, spectroscopy reagents, X-ray crystallography reagents, chromatography reagents, electrophoresis reagents, immunoassay reagents, and protein fractionation reagents. The immunoassay reagents segment is estimated to account for the largest market share in 2018, mainly due to the ability to quickly and easily provide precise and accurate results for protein identification and separation, which form the initial steps for proteome analysis.

Critical questions the report answers:

# Where will all these developments take the industry in the long term?

# What are the upcoming trends in the proteomics market?

# Which segment provides the most opportunity for growth?

# Who are the leading vendors operating in this market?

# What are the opportunities for new market entrants?

By instrumentation technology, the spectroscopy segment is expected to account for the largest share of the proteomics market

The proteomics market, by instrumentation technology, is segmented into spectroscopy, chromatography, electrophoresis, protein microarrays, X-ray crystallography, surface plasmon resonance, and protein fractionation. The spectroscopy segment accounted for the largest market share in 2018. The ability of spectroscopy to quantify the complex structure of proteins on a large scale and its capability to integrate with other technologies for protein quantification make spectroscopy an indispensable tool in proteomics. This contributes to the large share of the segment.

Recent Developments:

# In October 2018, Waters Corporation launched its RenataDX Screening System.

# In October 2018, Thermo Fisher Scientific, Inc. (US) collaborated with Symphogen (Denmark) under which Symphogen will use the Thermo Scientific Q Exactive Plus Orbitrap liquid chromatography-tandem mass spectrometry (LC/MS/MS) system with its BioPharma Option to create, test, and validate platform workflows for intact and native mass analysis of therapeutic monoclonal antibody (mAb) mixtures.

# In July 2018, Thermo Fisher Scientific, Inc. (US) launched the Quadrupole-Orbitrap Mass Spectrometer.

# In May 2018, Agilent acquired Advanced Analytical Technologies, Inc. (US). This acquisition enhanced Agilent’s technology base to provide customers with a comprehensive set of solutions for next-generation sequencing workflows.

# In May 2018, PerkinElmer acquired Shanghai Spectrum Instruments Co., Ltd. (SSI) (China), one of the leading manufacturers of analytical instruments in China. This will help the firm in building its footprint in China through SSI’s localized leading market position.

Request Sample Pages@

https://www.marketsandmarkets.com/requestsampleNew.asp?id=731

North America to dominate the proteomics market during the forecast period

In 2018, North America dominated the global proteomics market, followed by Europe. Increasing investments in the development of structure-based drug designs, growing academic and government investments in genomics and proteomics research, rising demand for high-quality research tools for data reproducibility, and rising focus of stakeholders on research projects involving proteins, associated biomolecules, and genes are the factors propelling the growth of the market in the region.

Key Market Players

# Thermo Fisher Scientific, Inc. (US)

# Agilent Technologies, Inc. (US)

# Danaher Corporation (US)

# Merck KGaA (Germany)

# Waters Corporation (US)

Advanced Proteomics Research Technologies - A Major Breakthrough for Global Genomics Industry

This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies.

We salute industry experts helping companies survive and sustain in this economic pandemic; they are working day and night to help companies take rapid-decisions by finding

# Covid Impact on Proteomics Market, growth/decline in product type/use cases of Proteomics Market due to cascaded impact of Covid on Extended Ecosystem..

# How top 50 companies in Proteomics Market are making rapid shifts in their strategies as we speak here...

# Outside-in view of top 50 companies client and client’s clients shifting short-term priorities

Let’s fight this crisis together.

Download PDF Brochure@ 

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=731

By instrumentation technology, the spectroscopy segment is expected to account for the largest share of the proteomics market

The proteomics market, by instrumentation technology, is segmented into spectroscopy, chromatography, electrophoresis, protein microarrays, X-ray crystallography, surface plasmon resonance, and protein fractionation. The spectroscopy segment accounted for the largest market share in 2018. The ability of spectroscopy to quantify the complex structure of proteins on a large scale and its capability to integrate with other technologies for protein quantification make spectroscopy an indispensable tool in proteomics. This contributes to the large share of the segment.

The use of immunoassay reagents is increasing with the rising need for precise protein identification

Based on reagent, the proteomics market is segmented into protein microarray reagents, spectroscopy reagents, X-ray crystallography reagents, chromatography reagents, electrophoresis reagents, immunoassay reagents, and protein fractionation reagents. The immunoassay reagents segment is estimated to account for the largest market share in 2018, mainly due to the ability to quickly and easily provide precise and accurate results for protein identification and separation, which form the initial steps for proteome analysis.

Recent Developments

# In October 2018, Waters Corporation launched its RenataDX Screening System

# In October 2018, Thermo Fisher Scientific, Inc. (US) collaborated with Symphogen (Denmark) under which Symphogen will use the Thermo Scientific Q Exactive Plus Orbitrap liquid chromatography-tandem mass spectrometry (LC/MS/MS) system with its BioPharma Option to create, test, and validate platform workflows for intact and native mass analysis of therapeutic monoclonal antibody (mAb) mixtures.

# In July 2018, Thermo Fisher Scientific, Inc. (US) launched the Quadrupole-Orbitrap Mass Spectrometer

# In May 2018, Agilent acquired Advanced Analytical Technologies, Inc. (US). This acquisition enhanced Agilent’s technology base to provide customers with a comprehensive set of solutions for next-generation sequencing workflows.

# In May 2018, PerkinElmer acquired Shanghai Spectrum Instruments Co., Ltd. (SSI) (China), one of the leading manufacturers of analytical instruments in China. This will help the firm in building its footprint in China through SSI’s localized leading market position.

Request Sample Pages@ 

https://www.marketsandmarkets.com/requestsampleNew.asp?id=731

North America to dominate the proteomics market during the forecast period

In 2018, North America dominated the global proteomics market, followed by Europe. Increasing investments in the development of structure-based drug designs, growing academic and government investments in genomics and proteomics research, rising demand for high-quality research tools for data reproducibility, and rising focus of stakeholders on research projects involving proteins, associated biomolecules, and genes are the factors propelling the growth of the market in the region.

Prominent players in the proteomics market are Thermo Fisher Scientific, Inc. (US), Agilent Technologies, Inc.(US), GE Healthcare (US), Bio-Rad Laboratories, Inc. (US), Danaher Corporation (US), Luminex Corporation (US), Bruker Corporation (US), Merck KGaA,(Germany), Waters Corporation (US), PerkinElmer, Inc. (US), Creative Proteomics (US), and Promega Corporation (US).

Critical questions the report answers:

# Where will all these developments take the industry in the long term?

# What are the upcoming trends in the proteomics market?

# Which segment provides the most opportunity for growth?

# Who are the leading vendors operating in this market?

# What are the opportunities for new market entrants?

Proteomics Research - All You Need to Know About Emerging Innovations

This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies.

Following are the Major Objectives of this Study:

# To define, describe, segment, and forecast the global proteomics market by instrumentation technology, reagent, services and software, application, end user, and region.

# To provide detailed information about the factors influencing market growth (such as drivers, restraints, opportunities, and industry-specific challenges)

# To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market

# To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players

# To forecast the size of the proteomics market in five main regions along with their respective key countries (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa)

# To profile key players in the global proteomics market and comprehensively analyze their core competencies and market shares

# To track and analyze competitive developments such as acquisitions; product launches; expansions; collaborations, partnerships, & agreements; and R&D activities of the leading players in the proteomics market

Find More Details | Download PDF Brochure@ 

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=731

Recent Developments:

# In 2018, Thermo Fisher Scientific, Inc. and Symphogen formed a collaboration under which Symphogen will use the Thermo Scientific Q Exactive Plus Orbitrap LC/MS/MS system with its BioPharma Option to create, test, and validate platform workflows for intact and native mass analysis of therapeutic monoclonal antibody (mAb) mixtures.

# In 2018, Thermo Fisher Scientific, Inc. launched TSQ Fortis Triple Quadrupole Mass Spectrometer and UHPLC-MS Ultrapure Solvents.

# In 2018, Agilent Technologies acquired Advanced Analytical Technologies, Inc. to enhance its technology base and provide a comprehensive set of solutions for NGS workflows.

# In 2017, Merck KGaA signed an MoU with Samsung BioLogics for a strategic alliance on biopharmaceutical manufacturing and biologics process development. Under the agreement, Merck would supply Mobius single-use systems, cell line, cell culture media, and chromatography to accelerate the development of biologic drugs.

Critical questions answered in the report:

# How will the current technological trends affect the proteomics market in the long term?

# How is the service market for proteomics moving?

# What are the application areas of the market?

# Which regions are likely to grow at the highest CAGR?

# What are the growth strategies being implemented by major market players?

Factors Influencing Global Growth:-

Growth in this market is driven by an increase in research activity (especially in the areas of personalized medicine and drug discovery). Other market drivers include increasing pharmaceutical and biotechnology R&D expenditure, government funding for proteomics, and technological advancements.

Restraints:

# High Cost of Instruments

Opportunities

# Growing Prominence of Nanoproteomics—The Convergence of Nanotechnology and Proteomics

# Personalized Proteomics for Precision Health

# High Growth Opportunities in Emerging Countries

Challenges:

# Data Management in Proteomics Research

# Low Biomarker Discovery-To-Approval Ratio

Request Sample Pages@ 

https://www.marketsandmarkets.com/requestsampleNew.asp?id=731

Monetary Growth Expectations, Globally:

According to the Research Study conducted by MarketsandMarkets™: The proteomics market is projected to reach USD 38.7 billion by 2024 from USD 19.5 billion in 2019, at a CAGR of 14.7%.

Geographical Growth Scenario:

In 2018, North America dominated the global proteomics market, followed by Europe. Increasing investments in the development of structure-based drug designs, growing academic and government investments in genomics and proteomics research, rising demand for high-quality research tools for data reproducibility, and rising focus of stakeholders on research projects involving proteins, associated biomolecules, and genes are the factors propelling the growth of the market in the region.

Leading Market Players:

# Thermo Fisher Scientific, Inc. (US)

# Agilent Technologies, Inc.(US)

# GE Healthcare (US)

# Bio-Rad Laboratories, Inc. (US)

# Danaher Corporation (US)

# Luminex Corporation (US) and many more…

These companies are focusing on increasing their presence in the high-growth markets through both organic as well as inorganic growth strategies such as product launches, acquisitions, partnerships, agreements, collaborations, joint ventures, and expansions.

Electrosurgery Market - Global Growth Strategies Adopted by Major Industry Leaders

The global Electrosurgery Market is expected to grow at a CAGR of 3.9% between 2016 and 2021. Factors such as technological advancements in electrosurgical devices, growing number of medical, aesthetic, and plastic surgeries, rising demand for minimally invasive surgeries, increasing number of ambulatory surgery centers are driving the growth of this market. 

On the other hand, healthcare reforms in the U.S., frequent product recalls, and risks associated with electrosurgical procedures are some of the key factors limiting the growth of the market.

The major players in the global electrosurgery market include Covidien plc (Ireland) (subsidiary of Medtronic (Ireland)), Ethicon, Inc. (U.S.) (subsidiary of Johnson & Johnson (U.S.)), Olympus Corporation (Japan), CONMED Corporation (U.S.), Erbe Elektromedizin GmbH (Germany), Bovie Medical Corporation (U.S.), B. Braun Melsungen AG (Germany), and BOWA-electronic GmbH & Co. KG (Germany). 

Analysis of the market developments between 2013 and 2016 reveals that product launches, regulatory approvals, and expansions were the most widely adopted growth strategies by players in the global electrosurgery market. 

Players adopted these strategies to strengthen their product portfolios and maintain a competitive position in the market. Ethicon, Inc. (U.S.), Olympus Corporation (Japan), Erbe Elektromedizin GmbH (Germany), Bovie Medical Corporation (U.S.), and BOWA-electronic GmbH & Co. KG (Germany) are some of the key players that primarily adopted these strategies. Acquisitions, agreements, and partnerships are some other strategies adopted by market players.

You Can Also Talk to Our Research Experts to Get More Detailed Information on This Study

Covidien plc (Medtronic) (Ireland) held the leading position in the global electrosurgery market in 2015. The company’s electrosurgery product portfolio is segmented in four broad categories–electrosurgical hardware, electrosurgical instruments, smoke evacuation systems, and vessel sealing. The company focuses on product innovation as its key growth strategy to sustain its leadership position in the electrosurgery market. For instance, in 2015, the company invested USD 2.22 billion on R&D activities, as compared to USD 1.64 billion in 2014; an increase of 35.6% as compared to that of the previous year. 

Ethicon, Inc. (subsidiary of Johnson & Johnson (U.S.)) held the second position in the electrosurgery market in 2015. The company offers products in advanced energy, ligation, hernia repair & fixation, surgical stapling, uterine & pelvic surgery, wound closure, and biosurgery. The company primarily focuses on expanding its electrosurgery product portfolio through the development and launch of technologically advanced products in order to strengthen its footprint in the market. For instance, in October 2016, the company launched HARMONIC HD 1000i Shears, its new high-precision ultrasonic shears. 

Stakeholders:

# Electrosurgical Instruments Manufacturing Companies

# Electrosurgical Instruments Accessories Manufacturing Companies

# Medical Device Suppliers and Distributors

# Hospitals and Clinics

# Research Laboratories and Academic Institutes

# Venture Capitalists and Other Government Funding Organizations

# Research and Consulting Firms

Read More@ 
https://www.marketsandmarkets.com/Market-Reports/electrosurgery-market-142006761.html

Growing Applications of Nanotechnology Boosts the Technological Innovations in Global Proteomics Research Industry

The global proteomics market exhibits potential for significant growth and is propelled by the increasing need for personalized medicine, R&D expenditure, technological advancements, and increased funding for proteomics projects. However, a few pivotal factors hampering the growth of this market include the reduced funds in key markets, sequestration cuts in the U.S. and reduced funds for proteomics research, high cost of tools and equipment, and dearth of skilled researchers.

Download the PDF Brochure for More Details@ https://www.marketsandmarkets.com/pdfdownload.asp?id=731

Key Market Restraints:
# Sequestration Cuts in the U.S. and Reduced Funds for Proteomic Research


# Huge Disconnect Between Biomarker Discovery and Biomarker Approval By Regulatory Authorities


# Expensive Tools and Instruments and Their Maintenance


Key Market Opportunities:
# Growing Applications of Nanotechnology
# Biomarker Identification
# Untapped Emerging Markets


Key Market Challenges:
# Managing Large Volumes of Data Generated in Proteomics Research
# Dearth of Skilled Researchers and Mandatory Training Cost

In 2015, North America accounted for the largest share of the proteomics market, followed by Europe. The large share of this regional segment can be attributed to factors such as easy availability of funds from various organizations for carrying out proteomic research using innovative technologies and stringent regulatory requirements regarding pharmaceutical manufacturing. The Asia-Pacific region is expected to witness the highest growth in this market majorly due to improving biopharmaceutical research infrastructure and growing economies in Japan and India. In addition, manufacturers are increasingly focusing on strengthening their presence in emerging markets of APAC countries.

The global proteomics market is fragmented in nature. Some key players in this market are Agilent Technologies Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Bruker Corporation (U.S.), Danaher Corporation (U.S.), GE Healthcare (U.S.), Luminex Corporation (U.S.), Merck KGaA (Germany), PerkinElmer Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), and Waters Corporation (U.S.). These leading players have primarily focused on new product launches, acquisitions, agreements, collaboration, partnerships, and expansions for growth in the market.

Target Audience

• Proteomics Instrumentation Technology Product Manufacturers
• Researchers and Scientists
• Proteomics Industry Consulting Firms
• Proteomics Research and Development (R&D) Companies
• Healthcare Institutions
• Research Institutes
• Market Research and Consulting Firms